Diagnostics and biomarkers companies develop technologies that detect, monitor and predict disease using biological markers, laboratory testing and analytical platforms. These tools play a critical role in modern healthcare and precision medicine.
This category includes companies working on:
Browse 252 UK diagnostics and biomarkers companies below.
Diagnostics and oral therapeutics for preeclampsia prevention
MirZyme Therapeutics develops diagnostic and therapeutic approaches aimed at preventing preeclampsia and fetal growth restriction. Its laboratory test assesses pregnancy risk using biomarkers combined with a clinical decision-support tool. The company is also developing oral treatments based on patented enzyme…
IVD manufacturer serving clinical laboratory and transfusion medicine
QuidelOrtho is a global in vitro diagnostics company with a major UK manufacturing and development facility in Pencoed, Wales, employing over 600 people. The site produces immunohematology reagents for transfusion medicine and immunoassay products covering infectious disease, endocrinology, and oncology testing,…
Liquid biopsy platform for isolating circulating tumour cells
Vortex Biosciences develops liquid biopsy technology for isolating circulating tumour cells from whole blood. Its automated, non-contact approach is designed to recover intact, viable cells that can be studied after collection. Preserving cell viability is important for molecular and functional analysis, rather than…
AI-powered immune profiling platform for precision medicine
IMU Biosciences is a biotechnology company coupling high-resolution, systems-level immune profiling with proprietary AI analytics to build a detailed atlas of the human immune system across health and disease. Its platform can identify and analyse over 2,000 immune cell subsets from blood samples, generating…
Circulating tumour cell liquid biopsy technology for cancer research and diagnostics
CelLBxHealth is a Guildford-based liquid biopsy company that develops and manufactures microfluidic circulating tumour cell harvesting technology and provides associated laboratory services. Its FDA-cleared instrument captures intact circulating tumour cells from blood samples for downstream genomic, transcriptomic,…
PCR platform enabling precision diagnostics on standard lab instruments
Signatur Biosciences is a biotechnology company developing a molecular diagnostic platform that encodes complex RNA gene expression signatures into single qPCR reactions. The technology enables precision diagnostics to be performed on standard laboratory instruments already present in clinical settings, removing…
Point-of-care diagnostics and AI triage for cancer patients
52North is a medical technology company developing diagnostics and digital tools for urgent cancer care. Its lead programme is a point-of-care blood test designed to help chemotherapy patients assess their risk of neutropenic sepsis outside hospital, alongside an AI-supported app for triaging acute oncology symptoms.…
Clinical and laboratory diagnostics systems for the UK market
Roche Diagnostics is the UK diagnostics subsidiary of F. Hoffmann-La Roche, based in Burgess Hill, West Sussex. The company supplies high-throughput laboratory analysers, reagents, and diagnostic software to NHS hospitals, clinical laboratories, and research institutions across the UK. Its portfolio spans clinical…
Cancer genetics testing and contract research
Oncologica provides molecular cancer diagnostics and contract research services from its laboratory at Chesterford Research Park near Cambridge. Its Oncofocus testing uses tumour DNA profiling to help clinicians identify potentially relevant targeted treatments and immunotherapies. The company also develops…
T cell-based tuberculosis diagnostics and clinical laboratory testing services
Oxford Immunotec is an Abingdon-based diagnostics company developing, manufacturing, and supplying T cell-based diagnostic tests for infectious and immunological diseases. Its platform measures specific T cell immune responses to inform clinical diagnosis, with the T-SPOT.TB test for tuberculosis detection cleared by…
Specialty enzyme manufacturer serving food, diagnostics and pharmaceutical industries
Amano Enzyme Europe is the UK subsidiary of Japanese specialty enzyme manufacturer Amano Enzyme Inc, serving as its EMEA hub. The company supplies microbial enzymes for food and beverage processing, dietary supplements, pharmaceutical manufacturing and clinical diagnostics. Its UK laboratories support enzyme…
Rapid diagnostic platforms for infectious disease and consumer testing
Sapphiros is a privately held diagnostics portfolio company backed by KKR and Neoenta. UK operations include Biocrucible, a molecular diagnostics company developing ultra-rapid isothermal nucleic acid amplification assays, and an Extreme Volume Manufacturing capability producing lateral flow diagnostic tests at…
T cell immune monitoring products and immunology contract research
ImmunoServ is a Welsh contract research and diagnostics company specialising in T cell immunology and cancer immunotherapy. The company develops and supplies standardised T cell testing kits that measure antigen-specific cellular immune responses from blood samples, with applications in infectious disease…
Ultrasensitive proteomics and biomarker assay development CRO
Altheome is a contract research organisation specialising in protein biomarkers and ultrasensitive proteomics for pharmaceutical, biotechnology and academic studies. Its services include custom assay development, biomarker discovery and validation, protocol optimisation and pharmacokinetic or pharmacodynamic analysis.…
Multiplex PCR pathogen detection kits for infectious disease diagnostics
Genetic Signatures is a molecular diagnostics company supplying multiplex real-time PCR detection kits for infectious disease testing in hospital and pathology laboratories. Its proprietary technology simplifies genetic sequences to improve multiplex efficiency and increase resistance to pathogen mutation,…
Rapid bacterial viability detection using optical electrophysiology
Cytecom is a biotechnology company developing instruments for the rapid detection and quantification of live bacteria. The company's platform combines fluorescence microscopy with electrical stimulation to assess bacterial membrane potential, distinguishing viable from non-viable cells within minutes. The technology…
Semiconductor biosensors for blood-based cancer biomarker detection
ExoNostic is a diagnostic technology company developing semiconductor biosensors for cancer biomarker detection. Its investigational lab-on-a-chip platform is designed to identify molecular signatures in small blood samples, combining sensor-based measurements with computational interpretation. An Innovate UK-funded…
Pre-cancer intervention to prevent cancer before it develops
Omos Biosciences is an early-stage biotechnology company developing approaches to cancer prevention through intervention at the pre-cancerous stage, rather than treatment of established disease. The company's strategy builds on established precedents in early cancer prevention, such as polyp removal to prevent…
Phage-based blood test for tuberculosis and mycobacterial disease
PBD Biotech is a diagnostics company that develops phage-based blood and milk tests for detecting active mycobacterial infections, including bovine tuberculosis, Johne's disease and human tuberculosis. Its proprietary technology uses bacteriophages to selectively infect live mycobacteria, enabling rapid, accurate…
Cell-free DNA capture reagents for liquid biopsy and cancer diagnostics
BIOCAPTIVA is a biotechnology company developing novel cell-free DNA capture technology to improve liquid biopsy for cancer research and diagnostics. Its proprietary polymer platform captures cfDNA directly from whole blood without centrifuges or additional reagents, delivering substantially higher cfDNA yields than…